MARGINAL ZONE LYMPHOMAS

Clinical trials for MARGINAL ZONE LYMPHOMAS explained in plain language.

Never miss a new study

Get alerted when new MARGINAL ZONE LYMPHOMAS trials appear

Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Early trial tests new combo for tough blood cancers

Disease control Completed

This early-stage study tested the safety and initial effectiveness of combining two drugs, acalabrutinib and pembrolizumab, for people with various blood cancers. It involved 161 participants with conditions like lymphoma and leukemia. The main goal was to see if the combination …

Matched conditions: MARGINAL ZONE LYMPHOMAS

Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

MARGINAL ZONE LYMPHOMAS

Get alerted when new MARGINAL ZONE LYMPHOMAS trials appear

Early trial tests new combo for tough blood cancers